Surgery Partners is listed on NASDAQ and receives analyst ratings from MarketBeat.
2 reports, 2 independent
Updated Aug 16
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Surgery Partners is listed on NASDAQ and receives analyst ratings from MarketBeat.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Surgery Partners
healthcare services company
-
Nasdaq
American fully electronic stock exchange
-
MarketBeat
American personal finance blog
Related events
- ProKidney and Cartesian Therapeutics were listed on the Nasdaq stock exchange and received ratings from MarketBeat.
- Two small-cap healthcare companies, Cardiff Oncology and CytomX Therapeutics, are listed on NASDAQ and receive analyst recommendations from MarketBeat.
- MarketBeat provided analyst ratings and targets for small-cap healthcare companies Emergent BioSolutions and Entrada Therapeutics.
- MarketBeat is providing analyst ratings and price targets for Driven Brands, a consumer discretionary company traded on the Nasdaq stock exchange, alongside Arko.
- BioHarvest Sciences Inc is listed on the Nasdaq stock exchange and is receiving analyst ratings and targets from MarketBeat.